EUVIMEDEUVIMED entdecken
Multizentrische StudieQuerschnittstudieOpen Access · CC BY 4.0

Current Trends in Revision Surgery After Breast Reconstruction in China: Insights from a Nationwide Cross-Sectional Survey

Yi Zhang, Qi Zhang, Yiding Chen, Shuang Hao, Benlong Yang, Yingying Zhang, Xuliren Wang, Zhibo Shao, Han Zhu, Bingqiu Xiu, Jiong Wu iD

Aesthetic Plastic Surgery · 2025

DOI: 10.1007/s00266-025-05490-8 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Aesthetic Plastic Surgery, 2025. Verfasst von Yi Zhang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Breast Surgery, Key Laboratory of Breast Cancer in Shanghai, Fudan University Shanghai Cancer Center, Shanghai, 200032, China. Hauptthemen laut MEDLINE: Reoperation, Mammaplasty, Mastectomy, Breast Neoplasms. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Program of Shanghai Academic Research Leader, Shanghai Committee of Science and Technology, Science and Technology Talent and Platform Program of the Yunnan Provincial.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Revision surgery is an integral component of post-mastectomy breast reconstruction, aimed at enhancing breast aesthetics and improving patient satisfaction. While developed countries have established high rates of revision surgery, its implementation in China remains limited. We aimed to evaluate the current practices and challenges of revision surgery in Mainland China using a nationwide cross-sectional survey.

Methods

A nationwide questionnaire authorized by the Chinese Anti-Cancer Association and related committees was distributed to 215 hospitals in China performing over 200 annual breast cancer surgeries, with 198 hospitals completed the survey. Data on nipple-areola complex reconstruction (NAR), autologous fat grafting (AFG), and contralateral breast symmetry surgery were collected and analyzed.

Results

Of the 198 surveyed hospitals, 23.2% performed NAR, 17.2% conducted AFG, and 26.8% carried out contralateral breast symmetry surgery, with only 6.6% providing all three. (1) NAR: Both the time intervals between primary breast reconstruction and NAR and the diverse techniques of NAR were to note. The use of autologous or allogenic implants has proven to improve long-term nipple projection (median nipple shrinkage rate 5.5% vs 30%; P < 0.001), but its usage was still limited. (2) AFG: AFG has wide application in breast reconstruction, with the most common use remaining the correction of deformities after lumpectomy (28/34, 82.4%) or breast reconstruction after mastectomy (21/34, 61.8%). (3) Contralateral breast symmetry surgery: Contralateral breast symmetry surgery was widely accepted by patients, and a simultaneous procedure was more favored (median 80% vs 20%; P < 0.001).

Conclusion

The implementation of revision surgery in China remains insufficient and unevenly distributed. Targeted efforts to expand specialized training, especially in plastic surgery, improve resource allocation, and adopt advanced techniques are essential. Level of Evidence IV This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ReoperationMammaplastyMastectomyBreast NeoplasmsHumansCross-Sectional StudiesFemaleChinaMiddle AgedSurveys and QuestionnairesAdultEstheticsPatient SatisfactionTreatment Outcome

Stichwörter der Autor:innen

Autologous fat graftingContralateral breast symmetry surgeryNational-wide cross-sectional studyNipple-areola complex reconstructionRevision surgery

Autor:innen und Institutionen

  • Department of Breast Surgery, Key Laboratory of Breast Cancer in Shanghai, Fudan University Shanghai Cancer Center, Shanghai, 200032, China.
  • Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China.
  • Department of Breast Surgery, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Cancer Institute (Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education), the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Department of Breast Surgery, Key Laboratory of Breast Cancer in Shanghai, Fudan University Shanghai Cancer Center, Shanghai, 200032, China. bingqiu_xiu@fudan.edu.cn.
  • Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China. bingqiu_xiu@fudan.edu.cn.

ORCID-Profile: Jiong Wu

Förderung

  • Program of Shanghai Academic Research Leader
  • Shanghai Committee of Science and Technology
  • Science and Technology Talent and Platform Program of the Yunnan Provincial

Zitieren

APA

Zhang, Y., Zhang, Q., Chen, Y., Hao, S., Yang, B., Zhang, Y., Wang, X., Shao, Z., Zhu, H., Xiu, B., & Wu, J. (2025). Current Trends in Revision Surgery After Breast Reconstruction in China: Insights from a Nationwide Cross-Sectional Survey. Aesthetic Plastic Surgery. https://doi.org/10.1007/s00266-025-05490-8

Vancouver

Zhang Y, Zhang Q, Chen Y, Hao S, Yang B, Zhang Y, et al. Current Trends in Revision Surgery After Breast Reconstruction in China: Insights from a Nationwide Cross-Sectional Survey. Aesthetic Plastic Surgery. 2025. doi:10.1007/s00266-025-05490-8

BibTeX
@article{Zhang2025,
  author = {Zhang, Yi and Zhang, Qi and Chen, Yiding and Hao, Shuang and Yang, Benlong and Zhang, Yingying and Wang, Xuliren and Shao, Zhibo and Zhu, Han and Xiu, Bingqiu and Wu, Jiong},
  title = {Current Trends in Revision Surgery After Breast Reconstruction in China: Insights from a Nationwide Cross-Sectional Survey},
  journal = {Aesthetic Plastic Surgery},
  year = {2025},
  doi = {10.1007/s00266-025-05490-8}
}
Kostenlos starten →